Calcium supplements in people with osteoporosis

BMJ (Online)

Volumn 341, Issue 7767, 2010, Pages 260-

  Cleland, John G F ^a   Witte, Klaus ^b   Steel, Sue ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; FLECAINIDE; LIPID; RALOXIFENE; THIAZIDE DIURETIC AGENT; VITAMIN D;

ARTERY WALL; BLOOD PRESSURE; BONE DENSITY; BONE INJURY; BONE STRENGTH; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIAGNOSTIC ERROR; DISEASE COURSE; DRUG COST; EDITORIAL; FALLING; FRACTURE; GASTROINTESTINAL SYMPTOM; HEALTH INSURANCE; HEART INFARCTION; HIP FRACTURE; HYPERTENSION; INCIDENCE; INCOME; LONGEVITY; MORTALITY; OSTEOPOROSIS; POPULATION RISK; PRIORITY JOURNAL; QUALITY OF LIFE; SITTING; STROKE; SUPPLEMENTATION; THORAX PAIN; VASCULAR DISEASE;

BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; DRUG THERAPY, COMBINATION; FRACTURES, BONE; HUMANS; MYOCARDIAL INFARCTION; OSTEOPOROSIS; STROKE; VITAMIN D;

EID: 77955364542     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3856     Document Type: Editorial

References (12)

1. Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691.[Abstract/Free Full Text]
2. Freemantle N, Calvert M. Composite and surrogate outcomes in randomised controlled trials. BMJ 2007;334:756-7.[Free Full Text]
3. Cleland JGF, Atkin SL. Thiazolidinediones, deadly sins, surrogates and elephants. Lancet 2007;370:1103-4.[CrossRef][Web of Science][Medline]
4. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 2007;370:657-66.[CrossRef][Web of Science][Medline]
5. Reid IR, Bolland MJ, Grey A. Effect of calcium supplementation on hip fractures. Osteoporos Int 2008;19:1119-23.[CrossRef][Web of Science][Medline]
6. Reid IR, Ames R, Mason B, Bolland MJ, Bacon CJ, Reid HE, et al. Effects of calcium supplementation on lipids, blood pressure, and body composition in healthy older men: a randomized controlled trial. Am J Clin Nutr 2010;91:131-9.[Abstract/Free Full Text]
7. Greenberg HM, Dwyer EM Jr, Hochman JS, Steinberg JS, Echt DS, Peters RW. Interaction of ischaemia and encainide/flecainide treatment: a proposed mechanism for the increased mortality in CAST I. Br Heart J 1995;74:631-5. [Abstract/Free Full Text]
8. Cleland JGF. For debate: preventing atherosclerotic events with aspirin. BMJ 2002;324:103-5.[Free Full Text]
9. Sahota O. Reducing the risk of fractures with calcium and vitamin D. BMJ 2010;340:b5492.[Free Full Text]
10. Stevenson M, Jones ML, De NE, Brewer N, Davis S, Oakley J. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol Assess 2005;9:1-160.[Medline]
11. Bolland MJ, Grey AB, Gamble GD, Reid IR. Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 2010;95:1174-81. [Abstract/Free Full Text]
12. Kanis JA, Brazier JE, Stevenson M, Calvert NW, Lloyd JM. Treatment of established osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess 2002;6:1-146.[Medline]